2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 (ED-71), preventive and therapeutic effects on bone mineral loss in ovariectomized rats
- 1 September 1993
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 3 (9) , 1815-1819
- https://doi.org/10.1016/s0960-894x(00)80111-0
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Regulatory activities of 2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolismBiochemical and Biophysical Research Communications, 1989
- Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton A trial of the development of vitamin D compounds which exhibit potent differentiation‐inducing activity without inducing hypercalcemiaFEBS Letters, 1987
- 24- and 26-homo-1,25-dihydroxyvitamin D3: preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro.Proceedings of the National Academy of Sciences, 1987
- Synthesis of mc 903, a biologically active vitamin D metabolite analogueTetrahedron, 1987
- Stereocontrolled total synthesis of 1.alpha.,25-dihydroxycholecalciferol and 1.alpha.,25-dihydroxyergocalciferolThe Journal of Organic Chemistry, 1986
- Synthesis of some side-chain homologues of 1.ALPHA.,25-dihydroxyvitamin D3 and investigation of their biological activities.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986